PPARG and urinary bladder carcinoma: However, in bladder cancer, studies have shown that PPARγ signaling could enhance the risk of developing bladder cancer (38, 39), and promote the progression and metastasis of bladder cancer via providing a tumor-promoting microenvironment (37, 40).